Cutting edge surgical Espana is born!

Montpellier – 22 January 2018 – Cutting Edge is proud to announce the opening of its Spanish offices, following successful registration of its newest IOLs, OVDs and retinal liquids & gas portfolios. Commercial …

Cutting edge gains saudi FDA approval

Montpellier – 20 May 2019 – Cutting Edge announced today that their Synthesis™ and Genesis™ Acrylic monofocal IOL platform has received Saudi Arabia FDA approval. The Genesis monofocal IOL is fully preloaded with SCREW or PUSH …

Cutting edge begins commercial operations in greece

Toulouse – 04 March 2020 – Cutting Edge is delighted to announce its Synthesis™ Toric -High Precision- IOL received clearance for use in Greece. Synthesis Toric is the newest innovation for safe, reproducible and MICS (Micro …

GENESIS – CE MARK APPROVAL mark approval

Cutting Edge SAS announced it received CE Approval for Genesis™ Hydrophobic Acrylic IOL. Montpellier – 25 April 2018 – Genesis, the latest addition of the Cutting Edge IOL portfolio, received CE Mark …

Synthesis preloaded iols now available in Italy

February 12, 2018, Montpellier, France. Cutting Edge SAS proudly announced today that our partner has successfully registered Synthesis Preloaded IOLs in the Italian Health’s Ministry Database. You could download our Ilalian leaflet by clicking HERE …